Tradipitant
Tradipitant is an experimental drug that is being developed by Vanda Pharmaceuticals. It is a neurokinin-1 receptor antagonist that is being studied for its potential use in the treatment of various medical conditions, including gastroparesis, chronic pruritus, and atopic dermatitis.
History[edit | edit source]
Tradipitant was originally developed by Merck & Co., but the development rights were later acquired by Vanda Pharmaceuticals. The drug is currently in clinical trials to evaluate its safety and efficacy in treating various conditions.
Mechanism of action[edit | edit source]
Tradipitant works by blocking the neurokinin-1 receptor, which is involved in various physiological processes, including pain perception, stress response, and inflammation. By blocking this receptor, tradipitant may help to alleviate symptoms associated with conditions like gastroparesis, chronic pruritus, and atopic dermatitis.
Clinical trials[edit | edit source]
Several clinical trials have been conducted to evaluate the safety and efficacy of tradipitant. These trials have shown promising results, but further research is needed to confirm these findings and to determine the optimal dosing regimen for this drug.
Potential uses[edit | edit source]
Tradipitant is being studied for its potential use in the treatment of various medical conditions, including:
- Gastroparesis: This is a condition in which the muscles in the stomach do not function properly, leading to delayed gastric emptying. Tradipitant may help to alleviate symptoms associated with this condition by blocking the neurokinin-1 receptor.
- Chronic pruritus: This is a condition characterized by persistent itching. Tradipitant may help to alleviate this symptom by blocking the neurokinin-1 receptor.
- Atopic dermatitis: This is a type of inflammation of the skin. Tradipitant may help to alleviate symptoms associated with this condition by blocking the neurokinin-1 receptor.
See also[edit | edit source]
| Tradipitant Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
